Therapeutic approach in elderly patients with polypharmacy by medical team: Prospective observational study

Therapeutic approach in elderly patients with polypharmacy by medical team: Prospective observational study - Polypharmacy reduction observational study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000024680

Enrollment

500

Registered

2016-11-02

Start date

2016-09-06

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polypharmacy

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1 Patients can ensure more than 2 weeks from observation initiation 2 Patients recieve 5 or more medications from 4 weeks ago 3 Patient can consent by a document

Exclusion criteria

Exclusion criteria: 1 Patient whose cannot consent in writing at the impact of dementia 2 Patients whose participation is deemed inappropriate at the discretion of the attending physician

Design outcomes

Primary

Measure	Time frame
To evaluate safety for the difference in the incidence of adverse drug reactions that polypharmacy patients (more than 5 agents) with the potentially inappropriate medications.	—

Countries

Japan

Contacts

Public ContactFumihiro Mizokami

National Center for Geriatrics and Gerontology Department of Pharmacy

mizokami@ncgg.go.jp0562-46-2311

Outcome results